AI assistant
Sending…
LANDMARK BANCORP INC — Director's Dealing 2016
Feb 22, 2016
33881_dirs_2016-02-22_19e37099-486d-4de6-849d-c3809aec3da1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANDMARK BANCORP INC (LARK)
CIK: 0001141688
Period of Report: 2016-02-18
Reporting Person: SCHEOPNER MICHAEL E (Director, President/CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-02-18 | Common Stock | M | 976 | $16.67 | Acquired | 53959 | Direct |
| 2016-02-18 | Common Stock | S | 976 | $24.673 | Disposed | 52983 | Direct |
| 2016-02-18 | Common Stock | M | 24 | $16.67 | Acquired | 53507 | Direct |
| 2016-02-18 | Common Stock | S | 24 | $24.75 | Disposed | 52983 | Direct |
| 2016-02-19 | Common Stock | M | 1400 | $16.67 | Acquired | 54383 | Direct |
| 2016-02-19 | Common Stock | S | 1400 | $24.75 | Disposed | 52983 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-18 | Options to Purchase Common Stock | $16.67 | M | 976 | Disposed | 2016-04-19 | Common Stock (976) | Direct |
| 2016-02-18 | Options to Purchase Common Stock | $16.67 | M | 24 | Disposed | 2016-04-19 | Common Stock (24) | Direct |
| 2016-02-19 | Options to Purchase Common Stock | $16.67 | M | 1400 | Disposed | 2016-04-19 | Common Stock (1400) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7925 | Indirect |
Footnotes
F1: The options vested in 4 equal installments on April 19, 2007, 2008, 2009, and 2010.
More from LANDMARK BANCORP INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 20
Annual Report
2026
Apr 14
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 12